Antibacterial Therapy in Adults with COVID-19

Since the emergence of the Coronavirus-19 infectious disease (COVID-19) pandemic, a rising number of reports have underlined the risk of increasing antimicrobial resistance due to antibiotic overuse in COVID-19 patients. In addition, many physicians and pharmacists involved in antimicrobial stewards...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Yhteisötekijät: Allard, Sabine Danielle, Van Laethem, Johan
Aineistotyyppi: Livro
Kieli:Inglês
Julkaistu: MDPI - Multidisciplinary Digital Publishing Institute 2023
Aiheet:
bic Book Industry Communication::M Medicine
bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine
COVID-19
antimicrobial use
multicentre
point-prevalence study
Influenza
co-infection
secondary infections
aspergillosis
ivermectin
randomized-controlled trial
prevention
treatment
SARS-CoV-2
antiviral
antibiotic
azithromycin
remdesivir
macrolides
virus
coronavirus
immunolides
antivirus
pandemics
procalcitonin
SARS virus
community-acquired infections
emergency service
hospital
pneumonia
viral
community-acquired pneumonia
Mid-regional Pro-adrenomedullin
ARDS
biomarker
prognosis
superinfection
bacterial co-infection
bacterial superinfection
antibiotic stewardship
AMR
antibiotics
cephalosporin
secondary infection
variant of concern
interleukin-6 receptor antagonist
early administration
mortality rates
Linkit:https://directory.doabooks.org/handle/20.500.12854/98801
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia